TGRX-814

N/A

Report date: 2024/04/28 14:15:38
NME

Base Information

Drug NameTGRX-814
Drug Alias NameTGRX-814
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsMyelodysplastic SyndromesHematologic NeoplasmsLymphoma, Non-Hodgkin +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen TargetRx Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen TargetRx Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesHematologic NeoplasmsLymphoma, Non-Hodgkin +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A